Nieves Martinez Lago MD PhD· @DraMartinezLago · X·· 2 天前评分90
正文 · 机器翻译
#ESMO26 💊 RAMIRIS | II/III 期
👥 317 例紫杉烷预治疗 GEA
🔀 FOLFIRI+Ram 对比 Pac+Ram
❌ 共同主要终点未达标
⏳ OS：8.7 对 7.5 个月（HR 0.95）
🎯 ORR：25.3% 对 22.6%
✅ PFS：5.5 对 3.7 个月（HR 0.70；p=.003）
⚠️ G≥3 不良事件：70% 对 68%
💡 PFS 获益但 OS 未改善
@OncoAlert
816 浏览 · 12 赞 · 12 转发 · 0 回复
会议摘要
1017P按 Developmental therapeutics 对上
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663按 - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy 对上
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.org来源：Nieves Martinez Lago MD PhD · x.com